A health body has won a patient safety award for administering a drug used to control blood clotting. North Norfolk Clinical Commissioning Group (NN CCG) was amongst the winners at the CCG Prescriber awards for its use of warfarin - one of the highest risk medications if incorrectly dosed.
GP practices within the group acheived a target range to manage blood clotting of 85pc for 1336 warfarin patients compared to an average of between 59-65pc.
The CCG also had the best INR monitoring rate, with 92pc of patients retested within 60 days.
NN CCG prescribing adviser Christine Walton said: 'We are really pleased to have been recognised for this award. Patient safety is one of our highest priorities so this is a great achievement for our GP practices.'
A total of 46 CCGs qualified for the awards with nominees in the top 10pc for performance in delivering medicine management.
Prescribing Services Ltd CCG liaison manager Keri Whitmore said: 'The opportunity to recognise CCG teams that are achieving excellence in patient safety is a core part of our conference each year. Congratulations to all the qualifying CCGs. Collectively you are leading the way in patient safety across the NHS.'
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here